iShares Biotechnology ETF (IBB)

iShares Biotechnology ETF (IBB $175.16)
- $175.16 P/E (TTM): 21.3X Cap: $8.75B
- View IBB Profile
- View Questions on IBB

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Intuitive Surgical Inc. (ISRG $523.69)
- $523.69 P/E (TTM): 70.67X Cap: $186.97B
- View ISRG Profile
- View Questions on ISRG
Vertex Pharmaceuticals Incorporated (VRTX $461.14)
- $461.14 P/E (TTM): 30.86X Cap: $112.16B
- View VRTX Profile
- View Questions on VRTX
AbbVie Inc. (ABBV $216.15)
- $216.15 P/E (TTM): 163.63X Cap: $378.29B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $218.01)
- $218.01 P/E (TTM): 21.11X Cap: $525.73B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $1,078.52)
- $1,078.52 P/E (TTM): 50.8X Cap: $984.41B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $111.11)
- $111.11 P/E (TTM): 14.39X Cap: $271.65B
- View MRK Profile
- View Questions on MRK
iShares Biotechnology ETF (IBB $175.16)
- $175.16 P/E (TTM): 21.3X Cap: $8.75B
- View IBB Profile
- View Questions on IBB
IDEXX Laboratories Inc. (IDXX $696.46)
- $696.46 P/E (TTM): 56.73X Cap: $55.61B
- View IDXX Profile
- View Questions on IDXX
Halozyme Therapeutics Inc. (HALO $71.71)
- $71.71 P/E (TTM): 16.12X Cap: $8.43B
- View HALO Profile
- View Questions on HALO
Incyte Corporation (INCY $104.67)
- $104.67 P/E (TTM): 17.54X Cap: $20.54B
- View INCY Profile
- View Questions on INCY
Catalyst Pharmaceuticals Inc. (CPRX $24.13)
- $24.13 P/E (TTM): 13.2X Cap: $2.87B
- View CPRX Profile
- View Questions on CPRX
Gilead Sciences CDR (CAD Hedged) (GILD $26.44)
- $26.44 P/E (TTM): 328.71X Cap: $210.04B
- View GILD Profile
- View Questions on GILD

Q: We have accumulated 11 healthcare stocks and 1 ETF, While LLY and ISRG are at half positions the rest are at initial 25% positions. Please advise [help!] us get to a more concentrated portfolio with a 3+ year horizon for reasonable opportunities in healthcare

Read Answer Asked by sam on January 13, 2026

iShares Biotechnology ETF (IBB $175.16)
- $175.16 P/E (TTM): 21.3X Cap: $8.75B
- View IBB Profile
- View Questions on IBB
State Street SPDR S&P Biotech ETF (XBI $128.18)
- $128.18 P/E (TTM): 18.21X Cap: $8.33B
- View XBI Profile
- View Questions on XBI
Natera Inc. (NTRA $242.78)
- $242.78 Cap: $32.48B
- View NTRA Profile
- View Questions on NTRA
ARK Genomic Revolution ETF (ARKG $32.40)
- $32.40 P/E (TTM): 41.03X Cap: $1.18B
- View ARKG Profile
- View Questions on ARKG
Catalyst Pharmaceuticals Inc. (CPRX $24.13)
- $24.13 P/E (TTM): 13.2X Cap: $2.87B
- View CPRX Profile
- View Questions on CPRX

Q: It looks like biotech stocks are on a tear, especially those that may benefit from AI. Do you have any names that you might recommend? I'm considering the Arkg fund but I don't quite trust Cathy Woods after losing money on the Arkk fund in 2021. Thank you,

Jason

Read Answer Asked by Jason on February 18, 2025

Biogen Inc. (BIIB $172.62)
- $172.62 P/E (TTM): 15.0X Cap: $25.32B
- View BIIB Profile
- View Questions on BIIB
Gilead Sciences Inc. (GILD $129.11)
- $129.11 P/E (TTM): 19.34X Cap: $154.01B
- View GILD Profile
- View Questions on GILD
Illumina Inc. (ILMN $152.48)
- $152.48 P/E (TTM): 32.64X Cap: $22.48B
- View ILMN Profile
- View Questions on ILMN
AbbVie Inc. (ABBV $216.15)
- $216.15 P/E (TTM): 163.63X Cap: $378.29B
- View ABBV Profile
- View Questions on ABBV
Abbott Laboratories (ABT $120.73)
- $120.73 P/E (TTM): 15.28X Cap: $210.64B
- View ABT Profile
- View Questions on ABT
Eli Lilly and Company (LLY $1,078.52)
- $1,078.52 P/E (TTM): 50.8X Cap: $984.41B
- View LLY Profile
- View Questions on LLY
Novo Nordisk A/S (NVO $59.32)
- $59.32 P/E (TTM): 17.71X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
iShares Biotechnology ETF (IBB $175.16)
- $175.16 P/E (TTM): 21.3X Cap: $8.75B
- View IBB Profile
- View Questions on IBB
State Street SPDR S&P Biotech ETF (XBI $128.18)
- $128.18 P/E (TTM): 18.21X Cap: $8.33B
- View XBI Profile
- View Questions on XBI
First Trust NYSE Arca Biotechnology ETF (FBT $37.26)
- $37.26 P/E (TTM): 21.4X Cap: $1M
- View FBT Profile
- View Questions on FBT

Q: Hi 5i, can you give me the names of 4 or 5 large cap pharmaceutical companies that are buyable now. Also I'm looking for 4 or 5 Biotech companies with one drug in the market making money and maybe something in the pipeline that looks like it has a good future? for example TGTX.

Read Answer Asked by Mark on January 09, 2025